Did that done that and it wasn't very pretty. I was asking for one of the "Long holders" to fast-track some light on the situation. Not everything is explained in black and white on a 10Q, sometime what is between the lines is what really matters.
My general summation of the company is that they have a great product that will enhance and save many lives, however they are having a difficult time making money doing it.
As for the European market, I assume it is smaller than the USA and the sales revenue from the US is a fraction of the operating expenses, leading me to believe profit is not in sight.
One ray of light came from the CEO explaining that the current manufacturing facility should be adequate throughout 2018. This statement resonates expanding sales.
News 
Market Data 
Discover 
